BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27388901)

  • 1. Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization.
    Vallerand D; Massonnet G; Kébir F; Gentien D; Maciorowski Z; De la Grange P; Sigal-Zafrani B; Richardson M; Humbert S; Thuleau A; Assayag F; de Plater L; Nicolas A; Scholl S; Marangoni E; Weigand S; Roman-Roman S; Savina A; Decaudin D
    PLoS One; 2016; 11(7):e0157670. PubMed ID: 27388901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 modulates mammary tumor progression in response to collagen density.
    Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
    Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusion between cancer cells and macrophages occurs in a murine model of spontaneous neu+ breast cancer without increasing its metastatic potential.
    Lizier M; Anselmo A; Mantero S; Ficara F; Paulis M; Vezzoni P; Lucchini F; Pacchiana G
    Oncotarget; 2016 Sep; 7(38):60793-60806. PubMed ID: 27563823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional Signature Derived from Murine Tumor-Associated Macrophages Correlates with Poor Outcome in Breast Cancer Patients.
    Tuit S; Salvagno C; Kapellos TS; Hau CS; Seep L; Oestreich M; Klee K; de Visser KE; Ulas T; Schultze JL
    Cell Rep; 2019 Oct; 29(5):1221-1235.e5. PubMed ID: 31665635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
    Boyle ST; Faulkner JW; McColl SR; Kochetkova M
    Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
    Yang J; Zhang Z; Chen C; Liu Y; Si Q; Chuang TH; Li N; Gomez-Cabrero A; Reisfeld RA; Xiang R; Luo Y
    Oncogene; 2014 Jun; 33(23):3014-23. PubMed ID: 23831570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.
    Werbeck JL; Thudi NK; Martin CK; Premanandan C; Yu L; Ostrowksi MC; Rosol TJ
    Vet Pathol; 2014 Jul; 51(4):868-81. PubMed ID: 24091811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
    Varticovski L; Hollingshead MG; Robles AI; Wu X; Cherry J; Munroe DJ; Lukes L; Anver MR; Carter JP; Borgel SD; Stotler H; Bonomi CA; Nunez NP; Hursting SD; Qiao W; Deng CX; Green JE; Hunter KW; Merlino G; Steeg PS; Wakefield LM; Barrett JC
    Clin Cancer Res; 2007 Apr; 13(7):2168-77. PubMed ID: 17404101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
    Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y
    Technol Cancer Res Treat; 2006 Dec; 5(6):565-71. PubMed ID: 17121432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.
    Grosset AA; Poirier F; Gaboury L; St-Pierre Y
    PLoS One; 2016; 11(11):e0166731. PubMed ID: 27902734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix stiffness enhances cancer-macrophage interactions and M2-like macrophage accumulation in the breast tumor microenvironment.
    Taufalele PV; Wang W; Simmons AJ; Southard-Smith AN; Chen B; Greenlee JD; King MR; Lau KS; Hassane DC; Bordeleau F; Reinhart-King CA
    Acta Biomater; 2023 Jun; 163():365-377. PubMed ID: 35483629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKCζ in prostate cancer cells represses the recruitment and M2 polarization of macrophages in the prostate cancer microenvironment.
    Fan HH; Li L; Zhang YM; Yang J; Li MC; Zeng FY; Deng F
    Tumour Biol; 2017 Jun; 39(6):1010428317701442. PubMed ID: 28631559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung Cancer.
    Poczobutt JM; De S; Yadav VK; Nguyen TT; Li H; Sippel TR; Weiser-Evans MC; Nemenoff RA
    J Immunol; 2016 Mar; 196(6):2847-59. PubMed ID: 26873985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.
    Cho RW; Wang X; Diehn M; Shedden K; Chen GY; Sherlock G; Gurney A; Lewicki J; Clarke MF
    Stem Cells; 2008 Feb; 26(2):364-71. PubMed ID: 17975224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
    Zhang M; Yan L; Kim JA
    Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.